Being totally honest during dental checkups can be challenging, especially when it comes to topics like flossing, sugar intake, and toothbrush replacement. In fact, 82% of people admitted to lying to their dental professional, with more than half (54%) saying they lie at least somewhat often.
Camber Pharmaceuticals announces the addition of ibuprofen and famotidine Tablets to its current portfolio.
MAPLE GROVE , Minn. – Upsher-Smith announced Tuesday the recent launch of vigadrone (vigabatrin) tablets, USP 500 mg, a fully substitutable, AB-rated generic version of Sabril (vigabatrin) Tablets, 500 mg. The company also offers vigadrone (vigabatrin) for Oral Solution, USP 500 mg.
Dry eyes, contact lens dryness, self- and pet-care and rising health consciousness among the general population continue to be key drivers of the eye care product market. John Ferris, executive vice president, Consumer, Bausch + Lomb, highlights eye care trends in 2023.
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application saxagliptin tablets, 2.5mg and 5mg.
In an unprecedented partnership, Chain Drug Review, Drug Store News, The Emerson Group and MMR are joining forces to celebrate the contributions of the National Association of Chain Drug Stores and community pharmacy retailers, as NACDS celebrates its 90th anniversary.
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of daptomycin for injection in both 350 mg and 500 mg strengths to its current portfolio.
RedSail Technologies, LLC, developer of Axys, is pleased to announce its integration with DosePlanner, a cloud-based medication management solution.
L’Oréal CEO Nicolas Hieronimus will deliver the first-ever keynote from a beauty company at CES 2024, the tech event announced on Wednesday.
ATLANTA, Ga. – As parents stock up the medicine cabinet for back-to-school season, Genexa has introduced its best-selling children’s product in a new organic flavor – Kids’ Pain & Fever Cherry.
MAPLE GROVE, Minn. – Upsher-Smith announced the recent launch of isotretinoin capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths.
Nirvana Water Sciences Corp. announced a further investment of $2.625 million by Flagstaff International, Inc. and other current investors.
After making strides in environmental sustainability and social impact commitments, Sanofi Consumer Healthcare North America announced it has earned B Corp Certification.
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of posaconazole delayed-release tablets to its current portfolio.
organizations representing dietary supplement manufacturers, marketers, and ingredient suppliers—applaud the introduction of the Dietary Supplements Access Act. This bipartisan legislation, introduced today by U.S.
